Amgen: all 1,085 studies

Page 3 of 11. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell LymphomaCompletedNCT03023878Phase 2Results posted
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated VasculitisCompletedNCT02994927Phase 3Results posted
• Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic ArthritisCompletedNCT02986139Phase 3Results posted
• A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's LymphomaCompletedNCT02961881Phase 1Results posted
• Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple MyelomaCompletedNCT02939183Phase 1Results posted
• Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to InfliximabCompletedNCT02937701Phase 3Results posted
• Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHLCompletedNCT02910063Phase 2/3Results posted
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label ExtensionCompletedNCT02867813Phase 3Results posted
• A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving HaemodialysisCompletedNCT02833857Phase 1Results posted
• Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed DyslipidemiaCompletedNCT02833844Phase 3Results posted
• Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean SubjectsCompletedNCT02802735Phase 1Results posted
• Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's AtaxiaCompletedNCT02797080Phase 3Results posted
• Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to RituximabCompletedNCT02792699Phase 3Results posted
• Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy FemalesCompletedNCT02792517Phase 1Results posted
• A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With OsteoporosisCompletedNCT02791516Phase 3Results posted
• A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid ArthritisCompletedNCT02780388Phase 1Results posted
• A Study to Evaluate the Pharmacokinetic Exposure of 2 Formulations of Apremilast in Healthy AdultsCompletedNCT02777554Phase 1Results posted
• Study of Talimogene Laherparepvec In Children With Advanced Non CNS TumorsCompletedNCT02756845Phase 1Results posted
• Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With ApremilastCompletedNCT02749370Phase 4Results posted
• Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to RituximabCompletedNCT02747043Phase 3Results posted
• Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous SumatriptanCompletedNCT02741310Phase 1Results posted
• Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed DyslipidemiaCompletedNCT02739984Phase 3Results posted
• Persistence With Prolia® (Denosumab) in Postmenopausal Women With OsteoporosisCompletedNCT02732210Results posted
• Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))CompletedNCT02729025Phase 3Results posted
• AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT02675452Phase 1Results posted
• Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed DyslipidemiaCompletedNCT02662569Phase 3Results posted
• Study to Evaluate Bioavailability of Apremilast Oral Suspension Relative to Tablet and to Assess Effect of Food on the Pharmacokinetics (PK) of the Oral SuspensionCompletedNCT02641353Phase 1Results posted
• A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac DiseaseCompletedNCT02637141Phase 2Results posted
• Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4CompletedNCT02634580Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac DiseaseCompletedNCT02633020Phase 2Results posted
• A Safety and Efficacy Study to Evaluate AMG 334 in Migraine PreventionCompletedNCT02630459Phase 2Results posted
• Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137)CompletedNCT02626000Phase 1Results posted
• Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)CompletedNCT02624869Phase 3Results posted
• Single Ascending Dose Study of AMG 570 in Healthy SubjectsCompletedNCT02618967Phase 1Results posted
• Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia StudyCompletedNCT02593773Phase 3Results posted
• Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study EnrollmentCompletedNCT02585895Phase 3Results posted
• A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT02576678Phase 2Results posted
• Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip ReplacementCompletedNCT02576652Phase 4Results posted
• Treadmill Cardiovascular Safety Study of Erenumab (AMG 334)CompletedNCT02575833Phase 2Results posted
• An Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016)CompletedNCT02574260Phase 2Results posted
• A Phase 1 Study in Subjects With Relapsed or Refractory Multiple MyelomaCompletedNCT02561962Phase 1Results posted
• To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine PatientsCompletedNCT02542605Phase 1Results posted
• Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced CancersCompletedNCT02526017Phase 1Results posted
• A Phase 1 Study of AMG 330 in Subjects With Myeloid MalignanciesTerminatedNCT02520427Phase 1Results posted
• Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611CompletedNCT02509507Phase 1/2Results posted
• Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine PreventionCompletedNCT02483585Phase 3Results posted
• A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial DiseaseTerminatedNCT02473445Phase 2Results posted
• Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell TumorCompletedNCT02471716Phase 1/2Results posted
• Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine PreventionCompletedNCT02456740Phase 3Results posted
• A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.CompletedNCT02425826Phase 4Results posted
• Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's AtaxiaCompletedNCT02415127Phase 3Results posted
• Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple MyelomaCompletedNCT02412878Phase 3Results posted
• Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaCompletedNCT02412306Phase 1/2Results posted
• Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)CompletedNCT02393859Phase 3Results posted
• Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) DisordersCompletedNCT02392559Phase 3Results posted
• Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS BlockadeCompletedNCT02384317Phase 2Results posted
• Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic ArthritisCompletedNCT02376790Phase 3Results posted
• Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis RemissionCompletedNCT02373813Phase 3Results posted
• Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected MelanomaCompletedNCT02366195Phase 2Results posted
• Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OITerminatedNCT02352753Phase 3Results posted
• Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid ArthritisTerminatedNCT02346877Phase 4Results posted
• Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on DialysisCompletedNCT02341417Phase 3Results posted
• Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple MyelomaCompletedNCT02335983Phase 1Results posted
• Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid TumorsCompletedNCT02318329Phase 1Results posted
• A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's DiseaseCompletedNCT02307513Phase 3Results posted
• Open-label Extension (OLE) Study to Assess Safety and Efficacy of EvolocumabCompletedNCT02304484Phase 3Results posted
• Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT02303821Phase 1Results posted
• A Phase 1 Study of AMG 211 in Participants With Advanced Gastrointestinal CancerTerminatedNCT02291614Phase 1Results posted
• Efficacy and Safety Study of Apremilast to Treat Active Ulcerative ColitisCompletedNCT02289417Phase 2Results posted
• A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid ArthritisCompletedNCT02287610Results posted
• Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)CompletedNCT02279173Phase 3Results posted
• Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of EvolocumabCompletedNCT02275156Phase 1Results posted
• Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque PsoriasisCompletedNCT02274792Phase 4Results posted
• Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected MelanomaTerminatedNCT02263508Phase 3Results posted
• Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving HemodialysisCompletedNCT02253654Phase 4Results posted
• A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle DisordersCompletedNCT02246218Phase 4Results posted
• Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy MenCompletedNCT02236988Phase 1Results posted
• Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated VasculitisCompletedNCT02222155Phase 2Results posted
• Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for MelanomaCompletedNCT02211131Phase 2Results posted
• Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk SubjectsCompletedNCT02207634Phase 3Results posted
• Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal AntibodyCompletedNCT02189837Phase 3Results posted
• A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With OsteoporosisCompletedNCT02186171Phase 3Results posted
• Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk ChemotherapyCompletedNCT02178475Results posted
• Darbepoetin Alfa MDS Companion ProtocolCompletedNCT02175277Phase 3Results posted
• A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.CompletedNCT02174861Phase 2Results posted
• A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With OsteoporosisCompletedNCT02157948Phase 3Results posted
• Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on DialysisTerminatedNCT02138838Phase 3Results posted
• Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid ArthritisCompletedNCT02114931Phase 3Results posted
• Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on HemodialysisCompletedNCT02102204Phase 3Results posted
• Effect of Denosumab on Cellular Biomarkers in the Human BreastCompletedNCT02099461Phase 1Results posted
• Nplate® Pregnancy Exposure RegistryTerminatedNCT02090088Results posted
• Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic DermatitisCompletedNCT02087943Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine PreventionCompletedNCT02066415Phase 2Results posted
• Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving DialysisCompletedNCT02054572Phase 1Results posted
• Bioequivalence Study of Denosumab CP4 Drug Product and Commercially Available Denosumab CP2 Drug ProductCompletedNCT02053753Phase 1Results posted
• Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial DiseaseCompletedNCT02023866Phase 2Results posted
• A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With OsteoporosisCompletedNCT02016716Phase 3Results posted
• Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene LaherparepvecCompletedNCT02014441Phase 2Results posted
• Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)TerminatedNCT02013167Phase 3Results posted
• Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic LeukemiaCompletedNCT02000427Phase 2Results posted

← Amgen overview and focus areas